ProQR Therapeutics
PRQR
PRQR
64 hedge funds and large institutions have $286M invested in ProQR Therapeutics in 2021 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
33.6% more ownership
Funds ownership: 52.68% → 86.28% (+34%)
21% more call options, than puts
Call options by funds: $2.48M | Put options by funds: $2.06M
Holders
64
Holding in Top 10
–
Calls
$2.48M
Puts
$2.06M
Top Buyers
| 1 | +$30.7M | |
| 2 | +$14M | |
| 3 | +$14M | |
| 4 |
Citigroup
New York
|
+$12.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$10.1M |
Top Sellers
| 1 | -$5.02M | |
| 2 | -$3.53M | |
| 3 | -$2.52M | |
| 4 |
Renaissance Technologies
New York
|
-$1.41M |
| 5 |
Millennium Management
New York
|
-$957K |